JoVE
JoVE
Faculty Resource Center
Research
Behavior
Biochemistry
Biology
Bioengineering
Cancer Research
Chemistry
Developmental Biology
Engineering
Environment
Genetics
Immunology and Infection
Medicine
Neuroscience
JoVE Journal
JoVE Encyclopedia of Experiments
JoVE Chrome Extension
Education
Biology
Chemistry
Clinical
Engineering
Environmental Sciences
Pharmacology
Physics
Psychology
Statistics
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Business
Videos Mapped to your Course
Authors
Librarians
High Schools
About
Sign-In
Sign In
Contact Us
Research
JoVE Journal
JoVE Encyclopedia of Experiments
Education
JoVE Core
JoVE Science Education
JoVE Lab Manual
High Schools
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Close
Research
Behavior
Biochemistry
Bioengineering
Biology
Cancer Research
Chemistry
Developmental Biology
Engineering
Environment
Genetics
Immunology and Infection
Medicine
Neuroscience
Products
JoVE Journal
JoVE Encyclopedia of Experiments
Education
Biology
Chemistry
Clinical
Engineering
Environmental Sciences
Pharmacology
Physics
Psychology
Statistics
Products
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Business
Videos Mapped to Your Course
Teacher Resources
Get in Touch
Instant Trial
Log In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Journal
/
Immunology and Infection
/
Screening of β2 Integrin Activation Inhibitors in Human Neutrophils
/
A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.
Sign in or start your free trial.
JoVE Journal
Immunology and Infection
A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs
A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs
Screening of β2 Integrin Activation Inhibitors in Human Neutrophils
DOI:
10.3791/64401-v
•
00:45 min
•
February 02, 2024
•
Ziming Cao
,
Matthew J. Garcia
,
Larry A. Sklar
3,4,5
,
Angela Wandinger-Ness
4
,
Zhichao Fan
1
Department of Immunology, School of Medicine
,
UConn Health
,
2
Center for Molecular Discovery
,
University of New Mexico Health Sciences Center
,
3
Comprehensive Cancer Center
,
University of New Mexico Health Sciences Center
,
4
Department of Pathology
,
University of New Mexico Health Sciences Center
,
5
Autophagy, Inflammation, & Metabolism (AIM) Center
,
University of New Mexico
Tags
Flow Cytometry
High-throughput Screening
Integrin Inhibitor
Beta-2 Integrin
Neutrophil
Anti-inflammatory
Conformational Change Antibody
FMLP
GPCR
Embed
ADD TO PLAYLIST
Usage Statistics
Related Videos
check_url/64401?article_type=v
A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs
check_url/64401?article_type=v
High-Throughput Screening of Compounds Using Neutrophils Isolated from Human Blood in a 384-Well Plate Format
check_url/64401?article_type=v
Neutrophils Screening Assay Using Flow Cytometry
Read Article